This event has already taken place.
Any recording and slides are available to ShareSoc members. Log in or join to access.
Company: Open Orphan (ORPH)
Presenter: Cathal Friel, Executive Chairman
Date: Monday 11th May 2020
Time: 5pm start – 6pm finish
Format: Webinar
Company Information:
Open Orphan is a newly created niche CRO pharmaceutical services company which is the world leader in testing vaccines & antivirals through human challenge studies. Open Orphan is actively involved in the fight against COVID-19 and is developing the world’s first coronavirus challenge study model.
In June 2019 Open Orphan acquired AIM-listed Venn Life Sciences plc in a reverse take-over and in January 2020 completed a merger with hVIVO plc. hVIVO has Europe’s only 24-bedroom quarantine clinic with onsite virology lab and has recently commenced testing on a potential antiviral treatment for COVID-19
Open Orphan (ORPH) is quoted on both the AIM and Euronext Growth market
Registration
Registration is open to members of ShareSoc. You need to be logged in to this website as a member to register. If you are not a member and would like to register, click here to join ShareSoc first. If you are a member and are not able to login, you will find instructions here.
If you are logged in, please click the button below to proceed to registration.
Register for Webinar